罕见病知识库 RareSeen

瓜氨酸血症

Citrullinemia

ORPHA:187疾病组中国目录 第1批 · 18

定义 英文原文(暂无中文)

Citrullinemia is an autosomal recessively inherited disorder of urea cycle metabolism and ammonia detoxification characterized by elevated concentrations of serum citrulline and ammonia. The disease presents with a large range of manifestations including neonatal hyperammonemic encephalopathy with lethargy, seizures and coma; hepatic dysfunction in all age groups; episodes of hyperammonemia and neuropsychiatric symptoms in children or adults, or, can be asymptomatic in some cases (detected in newborn screening programs). Citrullinemia is divided into two main groups that are encoded by different genes: citrullinemia type I (comprised of acute neonatal citrullinemia type I and adult-onset citrullinemia type I) and citrin deficiency (comprised of adult-onset citrullinemia type II and neonatal intrahepatic cholestasis due to citrin deficiency).

基本事实

遗传方式
常染色体隐性
发病年龄
成年期、新生儿期

相关基因 2来自下位疾病

Orphanet 未在本条目上直接标注致病基因。下表由本组所属的下位疾病汇总而来,「来源条目」列给出基因实际标注在哪一个 ORPHA 条目上。

基因名称来源条目
ASS1argininosuccinate synthase 1ORPHA:247546
SLC25A13solute carrier family 25 member 13ORPHA:247598

近两年的全球研究 246L2

2024/10 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。

  • 2026-09开放获取
    Cholestatic Liver Failure and Hypoglycemia in a Newborn: A Mitochondrial Pathology due to Citrin Deficiency
    Clinical case reports
  • 2026-09综述开放获取
    Acrodermatitis Dysmetabolica as a Cutaneous Manifestation of Isoleucine Deficiency in Maple Syrup Urine Disease: A Systematic Review of Reported Cases
    Health science reports · DOI · Europe PMC
  • 2026-09
    FGF21 elevation is a biomarker of citrin deficiency and its metabolic dysregulation in pediatric patients
    Molecular genetics and metabolism · DOI · Europe PMC
  • 2026-09开放获取
    Dried Blood Spot-Based Monitoring of Dietary Treatment in Children, Adolescents, and Young Adults with Inherited Disorders of Amino Acid Metabolism: A Four-Year Pilot Study
    Nutrients · DOI · Europe PMC
  • 2026-09开放获取
    Spectrum of inherited metabolic disorders diagnosed through newborn screening and symptomatic referrals in Eastern Türkiye
    Molecular genetics and metabolism reports · DOI · Europe PMC
  • 2026-09
    Sarcopenia in Pediatric Intoxication Type Inborn Errors of Metabolism: A Frequent and Underrecognized Condition
    Journal of inherited metabolic disease · 被引 1 · DOI · Europe PMC
  • 2026-08开放获取
    FoxO transcription factors coordinate the urea cycle and gluconeogenesis by controlling <i>Ass1</i>
    iScience · DOI · Europe PMC
  • 2026-08病例报告开放获取
    Recurrent Hyperammonemic Encephalopathy in Adults with Citrin Deficiency: A Case Report of Two Genetically Confirmed Cases
    Journal of clinical medicine · DOI · Europe PMC
  • 2026-08综述开放获取
    Induced Pluripotent Stem Cells in Non-Model Species: Applications and Challenges
    Cells · DOI · Europe PMC
  • 2026-08开放获取
    Feeding Intolerance and Citrulline Generation Test in the Critically Ill: A Prospective Study
    Nutrients · DOI · Europe PMC
  • 2026-08开放获取
    The Spanish Uniform Newborn Screening Panel (SUSP): A National Consensus Framework for Harmonized Newborn Screening
    International journal of neonatal screening · DOI · Europe PMC
  • 2026-08开放获取
    Pediatric hemorrhagic stroke in southern China: Analysis of 159 cases
    The Journal of international medical research · DOI · Europe PMC
  • 2026-08系统综述开放获取
    A systematic review and critical analysis of the evidence for transmission ratio distortion in humans
    Genetics · 被引 2 · DOI · Europe PMC
  • 2026-07开放获取
    Mitochondrial control of amino acid catabolism by a fasting-inducible mitochondrial carrier
    Science advances · DOI · Europe PMC
  • 2026-07综述开放获取
    A Comprehensive Meta-Analytical Investigation into the Incidence of Neonatal Amino Acid Metabolic Disorders Across China
    International journal of neonatal screening · DOI · Europe PMC
  • 2026-07开放获取
    Newborn Screening for Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency and Analysis of <i>SLC25A13</i> Gene Mutations in Hefei, China
    International journal of neonatal screening · DOI · Europe PMC
  • 2026-07开放获取
    Second-Tier Whole Exome Sequencing Following Abnormal Newborn Screening: Diagnostic Yield, Secondary Findings, and Carrier Burden in a Taiwanese Neonatal Cohort
    Children (Basel, Switzerland) · DOI · Europe PMC
  • 2026-07开放获取
    Neonatal Acute Liver Failure due to Citrin Deficiency (NALFCD)
    JIMD reports · DOI · Europe PMC
  • 2026-07开放获取
    <i>Cynara scolymus</i> Extract-Inulin Feed Additive Improves Intestinal Function and Growth in Weaned Piglets
    Animals : an open access journal from MDPI · DOI · Europe PMC
  • 2026-07开放获取
    Integrating telemedicine into nutritional management of infants with inherited metabolic disorders: a pilot study
    Frontiers in pediatrics · DOI · Europe PMC

境外已获批用于本病的药物 2L2

欧盟 1 项、美国 1 项。同一药物在两地各批一次的,会分别列出。

「境外已获批」不等于「在中国能用」。中间隔着进口注册、临床急需境外新药通道、海南博鳌乐城国际医疗旅游先行区等几条路径,各有各的条件与费用。这一节能确定地告诉你的只有一件事:这个病在世界范围内已经有获得批准的药物,它叫什么名字。拿这个名字去问主治医生,是下一步最省力的做法。

药名一律保留英文原文,不作翻译——中国的药品通用名与英文名的音译经常不一致,译错会让人去找一个不存在的药。

  • Ammonaps欧盟1999-12-07
    sodium phenylbutyrate
    官方记录
  • Ucephan美国1987-12-23
    Benzoate and phenylacetate
    该药获批用于瓜氨酸血症I型——本病种下的一个亚型
    官方记录
尚未获批的在研药物(5 项)

这些药已被欧盟或美国的监管机构认定为罕见病用药(英文 orphan drug designation,中文行业里通称「孤儿药资格」——「孤儿」说的是这类药市场太小、没有厂商愿意认领,不是在说病人)。但这只是一种监管身份:意味着监管机构给予研发上的激励,不代表这个药已被证明有效,也不代表将来一定能上市,绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。

  • Heparesc欧盟2009-10-08
    human heterologous liver cells
    该药获批用于瓜氨酸血症I型——本病种下的一个亚型
    Treatment of citrullinaemia type 1
    官方记录
  • Glyceryl tri-(4-phenylbutyrate)欧盟2010-06-10
    该药获批用于瓜氨酸血症II型——本病种下的一个亚型
    Treatment of citrullinaemia type 2
    官方记录
  • heterologous human adult liver-derived progenitor cells欧盟2013-07-17
    该药获批用于瓜氨酸血症I型——本病种下的一个亚型
    Treatment of citrullinaemia type 1
    官方记录
  • Prohippur欧盟2016-07-14
    sodium benzoate
    该药获批用于瓜氨酸血症I型——本病种下的一个亚型
    Treatment of citrullinaemia type 1
    官方记录
  • sodium phenylacetate;sodium benzoate欧盟2019-05-29
    该药获批用于瓜氨酸血症I型——本病种下的一个亚型
    Treatment of citrullinaemia type 1
    官方记录

数据来自欧洲药品管理局(EMA)的药品与罕见病用药资格公开导出表,以及美国 FDA 的罕见病用药资格数据库(Orphan Drug Product Designation Database)。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。

中国境外的在招试验 3L2

这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。

美国2澳大利亚1

共 3 项。

  • 尚未开始招募NCT07773246
    Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD
    I 期、II 期 · 干预性 · 2026/09Korro Bio, Inc.
    澳大利亚
  • 招募中NCT04908319
    Hepatic Histopathology in Urea Cycle Disorders
    观察性 · 2022/02/24Baylor College of Medicine
    美国
  • 招募中NCT04602325
    Systemic Biomarkers of Brain Injury From Hyperammonemia
    观察性 · 2020/07/09Children's National Research Institute
    美国

外部标识与链接

发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号

本页数据来源

  • 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
  • 中文病名:Orphanet 中文包,冻结于 2020-06-01
  • 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)